BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1645825)

  • 21. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.
    Lai EC; Choi TK; Tong SW; Ong GB; Wong J
    World J Surg; 1986 Jun; 10(3):501-9. PubMed ID: 2425500
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
    Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
    Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
    Kodama K; Kawaoka T; Aikata H; Uchikawa S; Nishida Y; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Kimura T; Nagata Y; Chayama K
    Oncology; 2018; 94(4):215-222. PubMed ID: 29428943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil.
    Kasugai H; Kojima J; Tatsuta M; Okuda S; Sasaki Y; Imaoka S; Fujita M; Ishiguro S
    Gastroenterology; 1989 Oct; 97(4):965-71. PubMed ID: 2550311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
    Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
    Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of survival in 240 patients with unresectable primary hepatocellular carcinoma treated with hepatic artery chemo-embolization].
    Cheng L; Wang Z; Cai F
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):362-4. PubMed ID: 9387276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
    Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
    J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study.
    Tong H; Wei B; Chen S; Xie YM; Zhang MG; Zhang LH; Huang ZY; Tang CW
    Oncotarget; 2017 Jul; 8(29):48303-48312. PubMed ID: 28430638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study.
    Chang JM; Tzeng WS; Pan HB; Yang CF; Lai KH
    Cancer; 1994 Nov; 74(9):2449-53. PubMed ID: 7922999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis.
    Chung YH; Song IH; Song BC; Lee GC; Koh MS; Yoon HK; Lee YS; Sung KB; Suh DJ
    Cancer; 2000 May; 88(9):1986-91. PubMed ID: 10813709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of treatment modalities for nonresectable primary liver cancer].
    Lin B; Li G; Yuan Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):310-3. PubMed ID: 9387331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
    Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
    Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
    Chia-Hsien Cheng J; Chuang VP; Cheng SH; Lin YM; Cheng TI; Yang PS; Jian JJ; You DL; Horng CF; Huang AT
    Int J Cancer; 2001 Aug; 96(4):243-52. PubMed ID: 11474499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: evaluation with analysis of 72 patients.
    Tang ZY; Uy YQ; Zhou XD; Ma ZC; Lu JZ; Lin ZY; Liu KD; Ye SL; Yang BH; Wang HW
    World J Surg; 1995; 19(6):784-9. PubMed ID: 8553666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.